What is Jazz Pharmaceuticals's marketing and selling?

Jazz Pharmaceuticals (JAZZ) reported marketing and selling of $21.4M in Q1 2026.

How has Jazz Pharmaceuticals's marketing and selling changed year-over-year?

Jazz Pharmaceuticals's marketing and selling decreased by 5.0% year-over-year, from $22.53M to $21.4M.

What is the long-term trend for Jazz Pharmaceuticals's marketing and selling?

Over 5 years (2020 to 2025), Jazz Pharmaceuticals's marketing and selling has grown at a 18.0% compound annual growth rate (CAGR), from $6.74M to $15.4M.

Jazz Pharmaceuticals JAZZ Marketing and selling

Marketing and selling at other companies

IncyteINCY

——

Other financials

Income statement

See full

Revenue$1.1B+19.1%

Operating income$336.6M+702%

Net income$293.1M+417%

EPS (diluted)$4.43+391%

Balance sheet

See full

Cash & equivalents$667.5M-64.1%

Total debt$5.4B-0.1%

Total equity$4.5B+8.6%

Total assets$11.9B+2.8%

Cash flow

See full

Operating cash flow$408.2M-5.0%

CapEx$19.7M+41.7%

Free cash flow$388.5M-6.6%

Valuation

See full

Market cap$14.11B+54.4%

Enterprise value$18.85B+47.7%

P/S3.2×+0.9×

Profitability

See full

Operating margin-11.9%-28.1pp

Net margin-8.9%-20.5pp

FCF margin28.6%-8.6pp

Returns & leverage

See full

Return on equity-9.1%-21.2pp

Debt / equity1.2×-0.1×

Current ratio2×-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccruedMarketingCostsCurrent.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's marketing and selling.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Jazz Pharmaceuticals's marketing and selling?: Jazz Pharmaceuticals (JAZZ) reported marketing and selling of $21.4M in Q1 2026.
How has Jazz Pharmaceuticals's marketing and selling changed year-over-year?: Jazz Pharmaceuticals's marketing and selling decreased by 5.0% year-over-year, from $22.53M to $21.4M.
What is the long-term trend for Jazz Pharmaceuticals's marketing and selling?: Over 5 years (2020 to 2025), Jazz Pharmaceuticals's marketing and selling has grown at a 18.0% compound annual growth rate (CAGR), from $6.74M to $15.4M.